Trastuzumab beyond disease progression: case closed?

J Clin Oncol. 2009 Sep 20;27(27):e121-2; author reply e124-5. doi: 10.1200/JCO.2009.23.8873. Epub 2009 Aug 17.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Antibodies, Monoclonal / therapeutic use*
  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Agents / therapeutic use*
  • Breast Neoplasms / drug therapy*
  • Breast Neoplasms / metabolism
  • Disease Progression
  • Female
  • Humans
  • Receptor, ErbB-2 / metabolism
  • Trastuzumab

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Agents
  • Receptor, ErbB-2
  • Trastuzumab